Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclomethasone dipropionate via breath-actuated inhaler or metered dose inhaler in persistent asthma
2013-003397-27Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of beclomethasone dipropionate in persistent asthma (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Change from baseline in trough morning FEV1 over 12 weeks. Started Jan 2014; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2013-003397-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003397-27.